Terms: = Prostate cancer AND TCF12, HEB, 6938, ENSG00000140262, HsT17266, HTF4 AND Prognosis
2 results:
1. Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive prostate cancer.
Vidal AC; Duong F; Howard LE; Wiggins E; Freedland SJ; Bhowmick NA; Gong J
Anticancer Res; 2020 Mar; 40(3):1459-1462. PubMed ID: 32132043
[TBL] [Abstract] [Full Text] [Related]
2. Decreased expression of tcf12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer.
Chen QB; Liang YK; Zhang YQ; Jiang MY; Han ZD; Liang YX; Wan YP; Yin J; He HC; Zhong WD
Tumour Biol; 2017 Jun; 39(6):1010428317703924. PubMed ID: 28651494
[TBL] [Abstract] [Full Text] [Related]
